Opioid-Prescribing Practices and Provider Confidence Recognizing Opioid Analgesic Abuse in HIV Primary Care Settings
Authors:
- Paula J LumPLPaula J Lum
- Sherri LittleSLSherri Little
- Michael BotskoMBMichael Botsko
- David HershDHDavid Hersh
- Robert E ThawleyRTRobert E Thawley
- James E EganJEJames E Egan
- Jennifer MittyJMJennifer Mitty
- Joshua BovermanJBJoshua Boverman
- David A FiellinDFDavid A Fiellin
- 1 March 2011
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 56 (Supplement) , S91-S97
Abstract
Pain syndromes are common in HIV-infected patients, who also are commonly affected by opioid-use disorders. Although opioids can treat pain, prescribers must consider the consequences of iatrogenic or missed addiction diagnoses. In an anonymous online survey, we asked a national sample of HIV providers about their demographics, experience, and patients, and their practices and attitudes about chronic opioid therapy, addiction, and confidence recognizing opioid analgesic abuse. One hundred six providers reported 28% of their patients had chronic pain; 21% received opioid analgesics; 37% were HIV infected by injecting drug use; and 12% were addicted to prescription opioids. Few providers followed recommended guidelines for chronic opioid therapy in nonmalignant pain. Mean provider confidence was 6.3 on a scale of 10. Higher confidence was associated with provider sex (P < 0.05), patient volume (P < 0.03), discussing substance use, (P < 0.05), urine toxicology (P < 0.01), prescribing longer acting opioids (P = 0.005), and prescribing buprenorphine (P = 0.009). HIV providers seldom follow recommended guidelines for opioid prescribing and have limited confidence in their ability to recognize opioid analgesic abuse. Clinical practices developed to reduce misuse and increase early detection and treatment of opioid dependence are associated with higher confidence. The implementation of guidelines to improve the quality of opioid prescribing in HIV clinics may aid in the diagnosis of addictive disorders and prevent their adverse outcomes.Keywords
This publication has 38 references indexed in Scilit:
- HIV-infected persons continue to lose kidney function despite successful antiretroviral therapyAIDS, 2009
- Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosisAIDS, 2009
- Factors affecting willingness to provide buprenorphine treatmentJournal of Substance Abuse Treatment, 2009
- Pain, problem drug use history, and aberrant analgesic use behaviors in persons living with HIVPain, 2007
- Development and validation of the Current Opioid Misuse MeasurePain, 2007
- Pharmacological pain control for human immunodeficiency virus–infected adults with a history of drug dependenceJournal of Substance Abuse Treatment, 2007
- The Addiction Behaviors Checklist: Validation of a New Clinician-Based Measure of Inappropriate Opioid Use in Chronic PainJournal of Pain and Symptom Management, 2006
- A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapyClinical Therapeutics, 2004
- Pain in ambulatory AIDS patients. II: Impact of pain on psychological functioning and quality of lifePain, 1996
- Sustained-release morphine sulfate in the management of pain associated with acquired immune deficiency syndromeJournal of Pain and Symptom Management, 1996